After implementing multiple Chemspeed platforms for various kinds of cutting edge materials research over the past 5 years, Prof. Andrew Cooper says:
Chemspeed SYNTHESIZER BIOMAT Platform helps CSIRO’s research on Drug Delivery Systems as illustrated in recent article in International Journal of Pharmaceutics
Catalyst screening is both a nightmare and the Holy Grail in selective synthesis. Companies like AstraZeneca have understood it very well. It is a nightmare because it is very difficult to predict which catalyst-ligand-solvent-additive combination and which conditions will lead to the best results
A project sponsored by Intelligent Formulation in the UK used the Chemspeed FORMAX at VLCI to gather Cc data on 22 green surfactants.
Chemspeed was recently granted a patent on Overhead Gravimetric Dispensing Technology, despite challenges from other market players